Lifecare AS Total Assets
Lifecare AS total assets. Based on the latest financial reports, Lifecare AS (LIFE) holds total assets worth Nkr62.95 Million NOK (≈ $6.62 Million USD) as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see LIFE market cap overview for the company's overall valuation and market capitalisation.
Total Assets of Lifecare AS (2015–2025)
Total assets of Lifecare AS from 2015 to 2025. This chart illustrates how Lifecare AS's total assets have evolved over time, based on quarterly financial data. See LIFE stock price for real-time trading data and today's change.
Lifecare AS - Asset Composition Analysis
Lifecare AS Total Assets Breakdown (December 2025)
Lifecare AS total assets breakdown as of December 2025. Lifecare AS's total assets of Nkr62.95 Million consist of 22.9% current assets and 77.1% non-current assets.
| Asset Category | Amount (NOK) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Nkr0.00 | 6.0% |
| Accounts Receivable | Nkr78.00K | 0.1% |
| Inventory | Nkr0.00 | 0.0% |
| Property, Plant & Equipment | Nkr0.00 | 0.0% |
| Intangible Assets | Nkr4.33 Million | 4.6% |
| Goodwill | Nkr7.23 Million | 7.6% |
Asset Composition Trend (2015–2025)
This chart illustrates how Lifecare AS's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore Lifecare AS current assets vs equity to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Lifecare AS's current assets represent 22.9% of total assets in 2025, a decrease from 94.9% in 2015.
- Cash Position: Cash and equivalents constituted 6.0% of total assets in 2025, down from 17.8% in 2015.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 11.0% of total assets, an increase from 5.0% in 2015.
- Asset Diversification: The largest asset category is goodwill at 7.6% of total assets.
Lifecare AS Competitors by Total Assets
Key competitors of Lifecare AS based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Medacta Group SA
SW:MOVE
|
Switzerland | CHF860.76 Million |
|
Vitrolife AB
ST:VITR
|
Sweden | Skr11.30 Billion |
|
Xiangyu Medical Co. Ltd. A
SHG:688626
|
China | CN¥3.27 Billion |
|
HOB Biotech Group Corp Ltd
SHG:688656
|
China | CN¥916.43 Million |
|
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317
|
China | CN¥3.66 Billion |
|
L&C Bio Co. Ltd
KQ:290650
|
Korea | ₩497.94 Billion |
|
Emvision Medical Devices Ltd
AU:EMV
|
Australia | AU$24.94 Million |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
Lifecare AS - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 11.69 | 3.34 | 2.59 |
| Quick Ratio | 11.69 | 3.34 | 2.59 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | Nkr41.27 Million | Nkr29.56 Million | Nkr3.54 Million |
Lifecare AS - Advanced Valuation Insights
This section examines the relationship between Lifecare AS's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.09 |
| Latest Market Cap to Assets Ratio | 0.18 |
| Asset Growth Rate (YoY) | -15.9% |
| Total Assets | Nkr94.65 Million |
| Market Capitalization | $16.60 Million USD |
Valuation Analysis
Below Book Valuation: The market values Lifecare AS's assets below their book value (0.18x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Lifecare AS's assets decreased by 15.9% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Lifecare AS (2015–2025)
The table below shows the annual total assets of Lifecare AS from 2015 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | Nkr94.65 Million ≈ $9.96 Million |
-15.94% |
| 2024-12-31 | Nkr112.59 Million ≈ $11.85 Million |
+30.33% |
| 2023-12-31 | Nkr86.39 Million ≈ $9.09 Million |
+23.46% |
| 2022-12-31 | Nkr69.97 Million ≈ $7.36 Million |
+117.16% |
| 2021-12-31 | Nkr32.22 Million ≈ $3.39 Million |
+120.56% |
| 2020-12-31 | Nkr14.61 Million ≈ $1.54 Million |
-16.49% |
| 2019-12-31 | Nkr17.49 Million ≈ $1.84 Million |
-25.29% |
| 2018-12-31 | Nkr23.42 Million ≈ $2.46 Million |
+1868.03% |
| 2017-12-31 | Nkr1.19 Million ≈ $125.22K |
-36.03% |
| 2016-12-31 | Nkr1.86 Million ≈ $195.73K |
-18.24% |
| 2015-12-31 | Nkr2.27 Million ≈ $239.39K |
-- |
About Lifecare AS
Lifecare ASA, together with its subsidiaries, operates as a medical sensor company that develops technology for sensing and monitoring of various body analytes in Norway and United Kingdom. The company develops Sencell, a 3D printed nano-sensor for monitoring glucose levels in patients with diabetes and for veterinary applications; as well as medical devices that remove subdermal implants. Lifeca… Read more